| Product NDC: | 55513-144 |
| Proprietary Name: | EPOGEN |
| Non Proprietary Name: | epoetin alfa |
| Active Ingredient(s): | 10000 [iU]/mL & nbsp; epoetin alfa |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55513-144 |
| Labeler Name: | Amgen Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103234 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19930816 |
| Package NDC: | 55513-144-10 |
| Package Description: | 10 VIAL in 1 PACKAGE (55513-144-10) > 1 mL in 1 VIAL (55513-144-01) |
| NDC Code | 55513-144-10 |
| Proprietary Name | EPOGEN |
| Package Description | 10 VIAL in 1 PACKAGE (55513-144-10) > 1 mL in 1 VIAL (55513-144-01) |
| Product NDC | 55513-144 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | epoetin alfa |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 19930816 |
| Marketing Category Name | BLA |
| Labeler Name | Amgen Inc |
| Substance Name | ERYTHROPOIETIN |
| Strength Number | 10000 |
| Strength Unit | [iU]/mL |
| Pharmaceutical Classes | Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE] |